Skip to main content

Table 1 Assessment schedule for patients recruited{13}

From: A pragmatic randomized controlled trial to evaluate the efficacy and safety of an oral short-course regimen including bedaquiline for the treatment of patients with multidrug-resistant tuberculosis in China: study protocol for PROSPECT

 

Study period

Phase

Screening

Study Treatment

Follow-up

Timepoint

W-8 to D-1

D1/BSL

W2

W4

W8

W12

W16

W20

W24

W28

W32

W36

W40

W52

W64

W76

W88

Enrolment:

 

 Screening

 

 Informed consent

X

                

 Inclusion/exclusion criteria

X

                

 Chest CT

X

    

X

  

X

  

X

     

 Medical history and demographics

X

                

 Pregnancy test

X

X

   

X

      

X

    

 HIV test

X

                

 Symptoms/weight

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

 Physical examination

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

 Randomization

 

X

               

Interventions:

 

 Dispense/administer allocated TB treatment

 

X

X

X

X

X

X

X

X

X

X

X

X

    

Assessments:

 

 Study treatment adherence assessment

  

X

X

X

X

X

X

X

X

X

X

X

X

   

 Efficacy and safety evaluations

 

 Sputum smear

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

 Sputum culture

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

 Molecular DST

X

                

 Collect strains for phenotypic DST (only in case of positive sputum culture)

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

 Visual acuity testing

X

X

X

X

X

X

X

X

X

X

X

X

X

    

 Urinalysis

X

X

X

X

X

X

X

X

X

X

X

X

X

    

 Hematology

X

X

X

X

X

X

X

X

X

X

X

X

X

    

 Clinical chemistrya

X

X

X

X

X

X

X

X

X

X

X

X

X

    

 Hepatitis B and C testing

 

X

               

 TSHb

X

X

   

X

  

X

        

 ECGc

X

X

X

X

X

X

X

X

X

X

X

X

X

    

 Ongoing participant review

 

 Concomitant therapy

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

 AEs

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

  1. X indicates assessments required at particular visits. BSL Baseline, CT Computerized tomography, D Day, W Week
  2. aWill include liver and kidney function tests and electrolytes and blood glucose measurement
  3. bWill be conducted at screening for all subjects; subsequent TSH testing will be conducted only if participant is receiving PTO
  4. cECG measurement should be continued during follow-up for patients whose bedaquiline course is extended to 40 weeks duration, and as clinically indicated to follow patients with increases in QTcF at the end of treatment until resolution